DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+27.53%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$130M
AUM Growth
+$130M
(+3%)
Cap. Flow
-$20.2M
Cap. Flow
% of AUM
-15.55%
Top 10 Holdings %
Top 10 Hldgs %
57.06%
Holding
85
New
23
Increased
8
Reduced
24
Closed
14
Top Buys
| 1 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
$2.19M |
| 2 |
OTIC
Otonomy, Inc.
OTIC
|
$1.77M |
| 3 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$1.65M |
| 4 |
Ascendis Pharma
ASND
|
$1.62M |
| 5 |
ESSA Pharma
EPIX
|
$1.42M |
Top Sells
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$10.1M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$5.61M |
| 3 |
OCRX
Ocera Therapeutics, Inc.
OCRX
|
$4.04M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$3.36M |
| 5 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$2.63M |
Sector Composition
| 1 | Healthcare | 56.42% |
| 2 | Financials | 0.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCYC
1
DELISTED
PHARMACYCLICS INC
PCYC
| $18.3M | 14.08% | 71,628 -39,300 | -35% | -$10.1M |
|
2
AtriCure
ATRC
$1.84B
| $13.1M | 10.03% | 637,431 -23,900 | -4% | -$490K |
|
|
ASPX
3
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $12.1M | 9.28% | 120,500 -15,385 | -11% | -$1.54M |
|
|
NXTM
4
DELISTED
NxStage Medical Inc.
NXTM
| $6.34M | 4.87% | 366,554 -17,600 | -5% | -$304K |
|
|
WINT
5
DELISTED
Windtree Therapeutics Inc
WINT
| $5.75M | 4.41% | 4,829,874 -868,865 | -15% | -$1.03M |
|
|
AERI
6
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.02M | 3.86% | 160,242 +27,800 | +21% | +$871K |
|
7
Rigel Pharmaceuticals
RIGL
$697M
| $3.96M | 3.04% | 1,109,740 +360,674 | +48% | +$1.29M |
|
8
Insulet
PODD
$23.9B
| $3.54M | 2.71% | 106,018 -3,400 | -3% | -$113K |
|
|
DSCI
9
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $3.17M | 2.43% | 373,918 -10,876 | -3% | -$92.1K |
|
10
Stereotaxis
STXS
$261M
| $2.82M | 2.16% | 1,372,862 -2,113 | -0.2% | -$4.33K |
|
|
MTEM
11
DELISTED
Molecular Templates, Inc.
MTEM
| $2.54M | 1.95% | 625,558 +94,593 | +18% | +$384K |
|
|
ACHN
12
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.38M | 1.83% | 241,600 +44,100 | +22% | +$435K |
|
13
Protalix BioTherapeutics
PLX
$124M
| $2.19M | 1.68% | 1,230,789 -153,100 | -11% | -$273K |
|
|
AGTC
14
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.19M | 1.68% | +109,323 | New | +$2.19M |
|
15
Masimo
MASI
$7.59B
| $2.18M | 1.67% | 66,000 -1,500 | -2% | -$49.5K |
|
|
BEAT
16
DELISTED
BioTelemetry, Inc.
BEAT
| $2.09M | 1.6% | 235,645 | – | – |
|
|
OTIC
17
DELISTED
Otonomy, Inc.
OTIC
| $1.77M | 1.36% | +50,000 | New | +$1.77M |
|
|
CLVS
18
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.74M | 1.33% | 23,400 -500 | -2% | -$37.1K |
|
|
NVDQ
19
DELISTED
Novadaq Technologies Inc.
NVDQ
| $1.65M | 1.27% | 101,841 -161,700 | -61% | -$2.63M |
|
|
ZSPH
20
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $1.65M | 1.26% | +39,100 | New | +$1.65M |
|
|
21
Ascendis Pharma
ASND
$11.8B
| $1.62M | 1.25% | +93,541 | New | +$1.62M |
|
|
EVFM
22
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $1.53M | 1.18% | 186,807 +312 | +0.2% | +$2.56K |
|
23
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.51M | 1.16% | 166,656 | – | – |
|
|
24
ESSA Pharma
EPIX
$11.4M
| $1.42M | 1.09% | +250,000 | New | +$1.42M |
|
|
SPNC
25
DELISTED
Spectranetics Corp
SPNC
| $1.38M | 1.06% | 39,812 -2,350 | -6% | -$81.7K |
|